Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010 Meeting Abstract
| Authors: | Ilson, D.; Moughan, J.; Safran, H.; Wigle, D.; Depetrillo, T.; Haddock, M.; Hong, T.; Leichman, L.; Rajdev, L.; Resnick, M.; Kachnic, L.; Seaward, S.; Mamon, H.; Dian Pardo, D.; Anderson, C.; Shen, X.; Sharma, A.; Katz, A.; Salo, J.; Leonard, K.; Crane, C. |
| Abstract Title: | Trastuzumab with trimodality treatment for esophageal adenocarcinoma with HER2 overexpression: NRG Oncology/RTOG 1010 |
| Meeting Title: | ESMO 22nd World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2020 Jul 1-4 |
| Meeting Location: | Virtual Conference |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-07-01 |
| Start Page: | S235 |
| Language: | English |
| ACCESSION: | WOS:000558722000434 |
| DOI: | 10.1016/j.annonc.2020.04.063 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O-10 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
